S2212, Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Colorado Cancer Research -
Location
-
Principal Investigator
-
Sponsor
SWOG
Enrollment Form
This study is currently enrolling.
